New QI Intervention Aids Pain Management for Seniors in the ER

Share this content:
New QI Intervention Aids Pain Management for Seniors in the ER
New QI Intervention Aids Pain Management for Seniors in the ER

MONDAY, Nov. 7, 2016 (HealthDay News) -- The Improving Pain Relief in Elder Patients (I-PREP) quality improvement (QI) intervention improves pain management in older adults in the emergency department, according to a study published online Nov. 2 in the Journal of the American Geriatrics Society.

Teresita M. Hogan, M.D., from the University of Chicago, and colleagues conducted a controlled pre/postintervention examination among patients aged 65 years and older with moderate-to-severe pain in an academic urban emergency department. A linked standardized education and continuous QI was conducted for multidisciplinary staff in an emergency department.

The researchers observed a 47.5 percent increase in the percentage of participants who had a final pain score of 4 or less out of 10. There was significant improvement in the median decrease in pain intensity, from 0.0 to 5.0 (P < 0.001), and a decrease in the median final pain score from 7.0 to 4.0 (P < 0.001). There was a 43.7 percent increase in the proportion of participants with any pain improvement (P < 0.001). A significant increase was seen in pain reassessments, from 51.9 to 82.5 percent (P < 0.001). There was a significant increase in the percentage of participants receiving analgesics, from 64.1 to 84.8 percent (P < 0.001). The odds of receiving analgesics and having a follow-up pain score documented were increased after the intervention (odds ratios, 3.1 and 4.7, respectively).

"The I-PREP intervention substantially improved pain management in older adults in the emergency department with moderate-to-severe musculoskeletal or abdominal pain," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »